查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771300

家用採血設備市場：產業趨勢及全球預測 - 依血液樣本狀況、樣本採集方法、設備用途、應用領域及主要地區

At Home Blood Collection Devices Market: Industry Trends and Global Forecasts - Distribution by Type of Blood Sample State, Method of Sample Collection, Device Usage, Area of Application, and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

全球家用採血設備概況

全球家用採血設備市場規模目前為 7.47億美元。預計預測期內，市場年複合成長率將達到 10.7%。

市場區隔包括根據以下參數進行的市場規模和機會分析：

血液樣本類型

  • 乾血樣本
  • 液體血液樣本

採樣方法

  • 指尖採血法
  • 按鈕採血法

設備用途

  • 一次性設備
  • 可重複使用設備

應用領域

  • 診斷
  • 研究
  • 治療
  • 其他

主要地區

  • 北美
  • 歐洲
  • 亞洲太平洋地區
  • 拉丁美洲
  • 中東和北非

全球家用採血設備的成長與趨勢

過去，採血具有侵入性，耗時長，並且需要專業醫護人員的協助。但近年來，家用採血方法已迅速發展。事實上，一項調查顯示，如果能夠提供自己採集的樣本（例如自體血），69%的參與者更有可能參與臨床試驗。因此，近年來家用檢測試劑盒的數量增加。

家用採血設備市場-IMG1

此外，在新冠疫情期間，為了保持社交距離並避免感染風險，對即時診療的需求有所增加，導致前往實驗室採集樣本和進行檢測的患者數量有所下降。這促使該領域的多個利益相關者開發新的設備和技術，使患者能夠在家中遠端採集血液樣本。隨著分子檢測技術的進步以及檢測所需樣本量的顯著減少，微型設備將診斷和監測平台轉變為即時診療應用。這項技術以採集微量血液樣本而聞名。此外，與侵入性極強且分析結果可能存在差異的傳統採樣技術相比，這些技術更加用戶友善。

全球家用採血設備關鍵洞察

本報告深入探討了全球家用採血設備的現狀，並識別了該行業的潛在成長機會。報告的主要調查結果包括：

  • 目前，市場上有近50種家用採血和微量採樣設備可供使用/開發中，其中大多數公司是位於美國的新創公司或小型企業。
  • 目前市面上大多數用於採集毛細血管全血的家用設備，其中用於製備乾血斑卡的DBS技術正成為最受歡迎的平台。
  • 最近，TAP® II和Tasso-M20自體血採集設備獲得了歐盟委員會的CE標誌認證。
  • 提供各種血液樣本的公司範例包括（依字母順序排列）：DBS System、Neoteryx、Sandstone Diagnostics和Sedia Biosciences。
  • 為了獲得競爭優勢，利害關係人積極擴展其產品組合，並透過融入先進功能來升級其設備。
  • 利害關係人日益成長的興趣也體現在近期合作活動的增加，迄今為止達成的交易中，很大一部分集中在市場擴張上。
家用採血設備市場-IMG2
  • 多年來，與採血設備相關的智慧財產權以驚人的速度成長，大多數專利是由產業參與者提交的。
  • 該領域申請/授予的專利數量以 11%的年複合成長率成長，2019年申請/授予的專利數量最多。
  • 高價值專利主要集中在血液樣本管理方面，包括樣本採集、穩定和儲存的系統和方法。
  • 大多數專利申請/授予地在北美，超過 90%的專利由該地區的行業參與者申請。
  • 為了支持該領域的持續創新，私人和公共投資者向各行業利益相關者發起的倡議投入 6.5億美元的巨額資本。
  • 該領域的融資和投資活動以 12%的年複合成長率成長。其中很大一部分的投資是在過去兩年內完成。
  • 除大型公司外，一些中小企業也透過 IPO、創投和其他股權融資。
家用採血設備市場-IMG3
  • 鑑於新冠疫情期間家用採血和微量採樣設備的普及率大幅提升，預計未來市場將呈現顯著成長。

家用採血設備市場的主要參與者

  • EuroImmun
  • Everlywell
  • LabCorp
  • LaBonovum
  • LamediTech
  • Quest Diagnostics
  • Spot-On Science
  • Tasso
  • Weaver Health
  • YourBioHealth

本報告調查全球家用採血設備市場，提供市場概述，以及依血液樣本狀況、樣本採集方法、設備用途、應用領域和區域的趨勢，和參與市場的公司簡介。

目錄

第1章 簡介

第2章 執行摘要

第3章 簡介

  • 章節概述
  • 家用採血和微量採樣設備概述
  • 血液樣本採集與檢測應用
  • 血液樣本類型
  • 家用採血的優勢
  • 家用採血的方法
  • 家用採血和微量採樣設備的類型
  • 未來展望

第4章 市場概述

  • 章節概述
  • 家用採血與微量採樣設備：市場格局
  • 家用採血和微量採樣設備：開發商列表
  • 最活躍的參與者：產品數量

第5章 產品競爭力分析

  • 章節概述
  • 假設與關鍵輸入參數
  • 研究方法

第6章 公司簡介

  • 章節概述
  • EUROIMMUN
  • Everlywell
  • Labcorp
  • Labonovum
  • Lameditech
  • Quest Diagnostics
  • Spot On Sciences
  • Tasso
  • Weavr Health
  • YourBio Health

第7章 專利分析

  • 章節概述
  • 家用採血和微量採樣設備：專利分析

第8章 合作夥伴關係

  • 章節概述
  • 合作模式
  • 家用血液和微量採樣設備：合作夥伴列表

第9章 資金與投資分析

  • 章節概述
  • 資金類型
  • 家用血液和微量採樣設備：資金和投資分析
  • 結論

第10章 成本節約分析

  • 章節概述
  • 關鍵假設
  • 方法論
  • 家用血液和微量採樣設備的整體成本節約潛力
  • 結論

第11章 市場預測

  • 章節概述
  • 預測研究方法論與假設
  • 2035年全球家用採血及微量採血設備市場
    • 2035年家用採血及微量採血設備市場：依血液樣本狀況
    • 2035年家用採血及微量採血設備市場：依血液檢體方式
    • 2035年家用採血及微量採血設備市場：依設備用途
    • 2035年家用採血及微量採血設備市場：依應用領域
    • 2035年家用採血及微量採血設備市場：依地區

第12章 結論

第13章 高層洞察

第14章 附錄1：表格資料

第15章 附錄2：公司與組織清單

Product Code: RA100301

GLOBAL AT HOME BLOOD COLLECTION DEVICES: OVERVIEW

As per Roots Analysis, the global at home blood collection devices valued at USD 747 million in the current year is anticipated to grow at a CAGR of 10.7% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Blood Sample State

  • Dried Blood Sample
  • Liquid Blood Sample

Method of Sample Collection

  • Fingerstick Method
  • Push-Button Method

Device Usage

  • Single-use Devices
  • Reusable Devices

Area of Application

  • Diagnostics
  • Research
  • Therapeutics
  • Other Areas of Applications

Key Geographical Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa

GLOBAL AT HOME BLOOD COLLECTION DEVICES: GROWTH AND TRENDS

Notably, in the past, approaches used for blood collection were invasive, time consuming and required a healthcare expert. However, in recent years, the methods for blood collection at home have evolved at a rapid pace. In fact, according to a research study, 69% of participants indicated that they would more likely participate in clinical trials if they had the option to provide self-collected samples like self-blood collection. Consequently, the number of at home testing kits have increased in the last few years.

At Home Blood Collection Devices Market - IMG1

Further, in the COVID-19 era, the demand for point of care treatment had increased to support physical distancing and avoid risk of infections, thus leading to a decline in number of patients visiting laboratories for sample collection and testing. Consequently, it encouraged several stakeholders in the domain to develop novel devices and technologies that can enable patients to collect blood samples remotely at home. With the advancements in molecular detection techniques and a significant reduction in the amount of sample required for testing, miniature devices are transforming diagnostic and monitoring platforms toward point-of-care applications. This technique is well known for capturing minute samples of blood. Moreover, these techniques are more user friendly, as compared to traditional sampling techniques which are highly invasive and may show variation in analysis.

GLOBAL AT HOME BLOOD COLLECTION DEVICES: KEY INSIGHTS

The report delves into the current state of global at home blood collection devices and identifies potential growth opportunities within the industry. Some key findings from the report include:

  • Presently, close to 50 at-home blood collection and micro sampling devices are available / being developed; majority of the firms engaged in this domain are startups or small companies located in the US.
  • Most of the at-home devices intended for collection of whole capillary blood are presently marketed; DBS technology, used for preparation of dried blood spot cards, has emerged as the most popular platform.
  • Recently, TAP(R) II and Tasso-M20 self-blood collecting devices received CE mark approval from the European Commission.
  • Examples of companies offering all types of blood samples include (in alphabetical order) DBS System, Neoteryx, Sandstone Diagnostics and Sedia Biosciences.
  • In pursuit of gaining a competitive edge, stakeholders are actively expanding their product portfolios and upgrading their devices, via incorporation of advanced features.
  • The growing interest of the stakeholders is also reflected from the recent rise in partnership activity; a significant proportion of the deals inked till date were focused on market expansion.
At Home Blood Collection Devices Market - IMG2
  • Over the years, the intellectual property related to blood collection devices has grown at a commendable pace, with majority of the patents being filed by industry players.
  • Number of patents filed / granted in this domain have increased at a CAGR of 11%, with maximum number of patents filed / granted in 2019.
  • The high value patents focus on blood sample management, including systems and methods for sample collection, stabilization and preservation.
  • Most of the patents were filed / granted in North America; in this region, more than 90% patents were filed by the industry players.
  • To support the ongoing innovation in this domain, private and public investors have made substantial capital investments, worth ~USD 650 million, in initiatives undertaken by various industry stakeholders.
  • Funding and investment activity in this domain has increased at a CAGR of 12%. A significant proportion of the total investment was made in the last two years.
  • In addition to large players, several mid-sized and small companies have raised funds through IPO, venture capitals and other equity.
At Home Blood Collection Devices Market - IMG3
  • Given the favourable increase in adoption of at-home blood collection and micro sampling devices during the COVID-19 pandemic, the market is anticipated to witness significant growth in the foreseen future.

Example Players in the At Home Blood Collection Devices

  • EUROIMMUN
  • Everlywell
  • Labcorp
  • Labonovum
  • Lameditech
  • Quest Diagnostics
  • Spot On Sciences
  • Tasso
  • Weavr Health
  • YourBio Health

GLOBAL AT HOME BLOOD COLLECTION DEVICES: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global antiviral drugs market, focusing on key market segments, including [A] type of blood sample state, [B] method of sample collection, [C] device usage, [D] area of application and [E] key geographical regions.
  • Market Landscape: A comprehensive evaluation of at-home self-blood collection and micro sampling devices, considering various parameters, such as [A] device class, [B] current status of development, [C] regulatory approvals / certifications received, [D] type of technology, [E] device usage, [F] type of sample, [G] blood sample state, [H] volume of sample collected, [I] puncture site, [J] method of sample collection, [K] storage temperature and [L] application area. Additionally, a comprehensive evaluation of the companies engaged in the development of at home blood collection and micro sampling devices, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters and [D] most active players (in terms of number of devices).
  • Company Profiles: In-depth profiles of companies engaged in at home blood collection devices market, focusing on [A] company overviews, [B] product portfolio and [C] recent developments and an informed future outlook.
  • Product Competitiveness Analysis: A comprehensive competitive analysis of at home blood collection and micro sampling devices, examining factors, such as [A] supplier power and [B] key product-related specifications.
  • Patent Analysis: An in-depth analysis of patents filed / granted till date in the at home blood collection devices domain, based on various relevant parameters, such as [A] type of patent, [B] publication year, [C] application year, [D] regional applicability, [E] CPC symbols, [F] emerging focus areas, [G] most active players (in terms of the number of patents filed / granted) and [H] patent valuation.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the global at home blood collection devices market, based on several parameters, such as [A] year of partnership, [B] type of partnership model adopted, [C] focus area, [D] therapeutic area and [E] regional distribution.
  • Funding and Investments: An in-depth analysis of the fundings received by players in at home blood collection devices market, based on relevant parameters, such as [A] year of investment, [B] number of funding instances, [C] amount invested, [D] type of funding, [E] most active players (in terms of number of funding instances and amount raised), [F] most active investors (in terms of number of funding instances), [G] geographical distribution, [H] purpose of investment and [I] application area.
  • Cost Saving Analysis: A comprehensive analysis of cost saving potential associated with the use of at-home self-blood collection and micro sampling devices examining various factors.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
  • 3.3. Applications of Blood Sampling and Testing
    • 3.3.1. Complete Blood Count
    • 3.3.2. Basic Metabolic Panel
    • 3.3.3. Lipoprotein Panel
  • 3.4. Types of Blood Sampling
    • 3.4.1. Dried Blood Sampling
    • 3.4.2. Wet Blood Sampling
  • 3.5. Benefits of At-Home Blood Collection
  • 3.6. Methods Used for At-Home Blood Collection
    • 3.6.1. Fingerstick Method
    • 3.6.2. Press Button Method
    • 3.6.3. Heel-stick Method
  • 3.7. Types of At-Home Blood Collection and Micro Sampling Devices
    • 3.7.1. Dried Blood Spot Collection Kits
    • 3.7.2. Microtainer Tubes
  • 3.8. Future Perspectives

4. MARKET OVERVIEW

  • 4.1. Chapter Overview
  • 4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
    • 4.2.1. Analysis by Device Class
    • 4.2.2. Analysis by Current Status of Development
    • 4.2.3. Analysis by Regulatory Approvals / Certifications Received
    • 4.2.4. Analysis by Type of Technology
    • 4.2.5. Analysis by Device Usage
    • 4.2.6. Analysis by Type of Sample
    • 4.2.7. Analysis by Blood Sample State
    • 4.2.8. Analysis by Volume of Sample Collected
    • 4.2.9. Analysis by Puncture Site
    • 4.2.10. Analysis by Method of Sample Collection
    • 4.2.11. Analysis by Storage Temperature
    • 4.2.12. Analysis by Application Area
  • 4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Geography
    • 4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
  • 4.4. Most Active Players: Analysis by Number of Products

5. PRODUCT COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Assumptions and Key Input Parameters
  • 5.3. Methodology
    • 5.3.1. Product Competitiveness Analysis: North America
    • 5.3.2. Product Competitiveness Analysis: Europe
    • 5.3.3. Product Competitiveness Analysis: Asia-Pacific

6. COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. EUROIMMUN
    • 6.2.1. Company Overview
    • 6.2.2. Product Portfolio
    • 6.2.3. Recent Developments and Future Outlook
  • 6.3. Everlywell
    • 6.3.1. Company Overview
    • 6.3.2. Product Portfolio
    • 6.3.3. Recent Developments and Future Outlook
  • 6.4. Labcorp
    • 6.4.1. Company Overview
    • 6.4.2. Product Portfolio
    • 6.4.3. Recent Developments and Future Outlook
  • 6.5. Labonovum
    • 6.5.1. Company Overview
    • 6.5.2. Product Portfolio
    • 6.5.3. Recent Developments and Future Outlook
  • 6.6. Lameditech
    • 6.6.1. Company Overview
    • 6.6.2. Product Portfolio
    • 6.6.3. Recent Developments and Future Outlook
  • 6.7. Quest Diagnostics
    • 6.7.1. Company Overview
    • 6.7.2. Product Portfolio
    • 6.7.3. Recent Developments and Future Outlook
  • 6.8. Spot On Sciences
    • 6.8.1. Company Overview
    • 6.8.2. Product Portfolio
    • 6.8.3. Recent Developments and Future Outlook
  • 6.9. Tasso
    • 6.9.1. Company Overview
    • 6.9.2. Product Portfolio
    • 6.9.3. Recent Developments and Future Outlook
  • 6.10. Weavr Health
    • 6.10.1. Company Overview
    • 6.10.2. Product Portfolio
    • 6.10.3. Recent Developments and Future Outlook
  • 6.11. YourBio Health
    • 6.11.1. Company Overview
    • 6.11.2. Product Portfolio
    • 6.11.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
    • 7.2.1. Scope and Methodology
    • 7.2.2. Analysis by Publication Year
    • 7.2.3. Analysis by Publication Year and Type of Patent
    • 7.2.4. Analysis by Geography
    • 7.2.5. Analysis by CPC Symbols
    • 7.2.6. Analysis by Emerging Focus Area
    • 7.2.7. Most Active Players: Analysis by Number of Patents
    • 7.2.8. Patent Benchmarking Analysis
    • 7.2.9. Patent Valuation Analysis
    • 7.2.10. Overall Intellectual Property Portfolio: Analysis by Type of Organization

8. PARTNERSHIPS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Year and Type of Partnership
    • 8.3.4. Analysis by Focus Area
    • 8.3.5. Analysis by Year of Partnership and Focus Area
    • 8.3.6. Analysis by Type of Partnership and Focus Area
    • 8.3.7. Analysis by Therapeutic Area
    • 8.3.8. Analysis by Region
      • 8.3.8.1. Continent-wise Distribution
      • 8.3.8.2. Intercontinental and Intracontinental Distribution
      • 8.3.8.3. Country-wise Distribution
    • 8.3.9. Most Active Players: Analysis by Number of Partnerships

9. FUNDING AND INVESTMENT ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Types of Funding
  • 9.3. At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
    • 9.3.1. Analysis of Number of Funding Instances by Year
    • 9.3.2. Analysis by Amount Invested
    • 9.3.3. Analysis by Type of Funding
    • 9.3.4. Analysis by Year and Type of Funding
    • 9.3.5. Analysis of Amount Invested by Geography
    • 9.3.6. Most Active Players: Analysis by Number of Funding Instances and Amount Invested
    • 9.3.7. Key Investors: Analysis by Number of Funding Instances
    • 9.3.8. Analysis by Purpose of Investment
    • 9.3.9. Analysis by Application Area
  • 9.4. Concluding Remarks

10. COST SAVING ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Key Assumptions
  • 10.3. Methodology
  • 10.4. Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices
  • 10.5. Concluding Remarks

11. MARKET FORECAST

  • 11.1. Chapter Overview
  • 11.2. Forecast Methodology and Assumptions
  • 11.3. Global At-Home Blood Collection and Micro Sampling Devices Market, Till 2035
    • 11.3.1. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Blood Sample State
      • 11.3.1.1. At-Home Blood Collection and Micro Sampling Devices Market for Dried Blood Samples, Till 2035
      • 11.3.1.2. At-Home Blood Collection and Micro Sampling Devices Market for Liquid Blood Samples, Till 2035
    • 11.3.2. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Method of Sample Collection
      • 11.3.2.1. At-Home Blood Collection and Micro Sampling Devices Market for Fingerstick Method of Sample Collection, Till 2035
      • 11.3.2.2. At-Home Blood Collection and Micro Sampling Devices Market for Push-Button Method of Sample Collection, Till 2035
    • 11.3.3. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Device Usage
      • 11.3.3.1. At-Home Blood Collection and Micro Sampling Devices Market for Single-use Devices, Till 2035
      • 11.3.3.2. At-Home Blood Collection and Micro Sampling Devices Market for Reusable Devices, Till 2035
    • 11.3.4. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Area of Application
      • 11.3.4.1. At-Home Blood Collection and Micro Sampling Device Market for Diagnostics, Till 2035
      • 11.3.4.2. At-Home Blood Collection and Micro Sampling Device Market for Research, Till 2035
      • 11.3.4.3. At-Home Blood Collection and Micro Sampling Device Market for Therapeutics, Till 2035
      • 11.3.4.4. At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, Till 2035
    • 11.3.5. At-Home Blood Collection and Micro Sampling Devices Market, Till 2035: Analysis by Region
      • 11.3.5.1. At-Home Blood Collection and Micro Sampling Devices Market in North America, Till 2035
      • 11.3.5.2. At-Home Blood Collection and Micro Sampling Devices Market in Europe, Till 2035
      • 11.3.5.3. At-Home Blood Collection and Micro Sampling Devices Market in Asia-Pacific, Till 2035
      • 11.3.5.4. At-Home Blood Collection and Micro Sampling Devices Market in Latin America, Till 2035
      • 11.3.5.5. At-Home Blood Collection and Micro Sampling Devices Market in MENA, Till 2035

12. CONCLUSION

13. EXECUTIVE INSIGHTS

  • 13.1. Chapter Overview
  • 13.2. Interview Transcript, Business Development Manager, Company A

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 3.1 Various Applications of Complete Blood Count Test
  • Table 3.2 Various Applications of Basic Metabolic Panel
  • Table 3.3 Various Applications of Lipoprotein Panel
  • Table 4.1 At-Home Blood Collection and Micro Sampling Devices: Current Market Landscape
  • Table 4.2 At-Home Blood Collection and Micro Sampling Devices: Information on Devices
  • Table 4.3 At-Home Blood Collection and Micro Sampling Devices: Information on Samples Collected
  • Table 4.4 At-Home Blood Collection and Micro Sampling Devices: Information on Type of Technology and Application Area
  • Table 4.5 At-Home Blood Collection and Micro Sampling Devices: List of Developers
  • Table 6.1 EUROIMMUN: Company Overview
  • Table 6.2 EUROIMMUN: Product Portfolio
  • Table 6.3 Everlywell: Company Overview
  • Table 6.4 Everlywell: Product Portfolio
  • Table 6.5 Everlywell: Recent Developments and Future Outlook
  • Table 6.6 Labcorp: Company Overview
  • Table 6.7 Labcorp: Product Portfolio
  • Table 6.8 Labonovum: Company Overview
  • Table 6.9 Labonovum: Product Portfolio
  • Table 6.10 Lameditech: Company Overview
  • Table 6.11 Lameditech: Product Portfolio
  • Table 6.12 Quest Diagnostics: Company Overview
  • Table 6.13 Quest Diagnostics: Product Portfolio
  • Table 6.14 Spot on Sciences: Company Overview
  • Table 6.15 Spot on Sciences: Product Portfolio
  • Table 6.16 Spot on Science: Recent Developments and Future Outlook
  • Table 6.17 Tasso: Company Overview
  • Table 6.18 Tasso: Product Portfolio
  • Table 6.19 Tasso: Recent Developments and Future Outlook
  • Table 6.20 Weavr Health: Company Overview
  • Table 6.21 Weavr Health: Product Portfolio
  • Table 6.22 Weavr Health: Recent Developments and Future Outlook
  • Table 6.23 YourBio Health: Company Overview
  • Table 6.24 YourBio Health: Product Portfolio
  • Table 7.1 Patent Analysis: List of Top CPC Symbols
  • Table 7.2 Patent Analysis: Summary of Benchmarking Analysis
  • Table 7.3 Patent Analysis: Various Categorizations based on Weighted Valuation Scores
  • Table 7.4 Patent Analysis: List of Leading Patents (In Terms of Highest Relative Valuation)
  • Table 8.1 At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
  • Table 8.2 Partnerships: Information on Focus Area and Therapeutic Area
  • Table 9.1 At-Home Blood Collection and Micro Sampling Device Market: Funding and Investments, Since 2013
  • Table 9.2 Funding and Investment Analysis: Summary of Investments
  • Table 9.3 Funding and Investment Analysis: Summary of Venture Capital Funding
  • Table 9.4 At-Home Blood Collection and Micro Sampling Device Market: Information on Purpose of Funding and Area of Application, Since 2013
  • Table 14.1 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Class
  • Table 14.2 At-Home Blood Collection and Micro Sampling Devices: Distribution by Current Status of Development
  • Table 14.3 At-Home Blood Collection and Micro Sampling Devices: Distribution by Regulatory Approvals / Certifications Received
  • Table 14.4 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Technology
  • Table 14.5 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Usage
  • Table 14.6 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Sample
  • Table 14.7 At-Home Blood Collection and Micro Sampling Devices: Distribution by Blood Sample State
  • Table 14.8 At-Home Blood Collection and Micro Sampling Devices: Distribution by Volume of Sample Collected
  • Table 14.9 At-Home Blood Collection and Micro Sampling Devices: Distribution by Puncture Site
  • Table 14.10 At-Home Blood Collection and Micro Sampling Devices: Distribution by Method of Sample Collection
  • Table 14.11 At-Home Blood Collection and Micro Sampling Devices: Distribution by Storage Temperature
  • Table 14.12 At-Home Blood Collection and Micro Sampling Devices: Distribution by Application Area
  • Table 14.13 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment
  • Table 14.14 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Company Size
  • Table 14.15 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Continent-wise)
  • Table 14.16 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Country-wise)
  • Table 14.17 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment, Company Size and Location of Headquarters
  • Table 14.18 Most Active Players: Distribution by Number of Products
  • Table 14.19 Most Active Players: Distribution by Current Status of Development
  • Table 14.20 Patent Analysis: Distribution by Type of Patent
  • Table 14.21 Patent Analysis: Cumulative Distribution by Publication Year, Since 2015
  • Table 14.22 Patent Analysis: Distribution by Type of Patent and Publication Year
  • Table 14.23 Patent Analysis: Distribution by Geography
  • Table 14.24 Patent Analysis: North America Scenario
  • Table 14.25 Patent Analysis: Asia-Pacific Scenario
  • Table 14.26 Most Active Players: Distribution by Number of Patents
  • Table 14.27 Patent Analysis: Distribution by Patent Age
  • Table 14.28 Overall Intellectual Property Portfolio: Distribution by Type of Organization
  • Table 14.29 Partnerships: Cumulative Year-wise Trend, Since 2016
  • Table 14.30 Partnerships: Distribution by Type of Partnership
  • Table 14.31 Partnerships: Distribution by Year and Type of Partnership
  • Table 14.32 Partnerships: Distribution by Focus Area
  • Table 14.33 Partnerships: Distribution by Type of Partnership and Focus Area
  • Table 14.34 Partnerships: Distribution by Therapeutic Area
  • Table 14.35 Partnerships: Continent-wise Distribution
  • Table 14.36 Partnerships: Country-wise Distribution
  • Table 14.37 Most Active Players: Distribution by Number of Partnerships
  • Table 14.38 Funding and Investment Analysis: Cumulative Year-wise Distribution of Number of Instances, Since 2013
  • Table 14.39 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Since 2013 (USD Million)
  • Table 14.40 Funding and Investment Analysis: Distribution by Type of Funding, Since 2013
  • Table 14.41 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding, Since 2013 (USD Million)
  • Table 14.42 Funding and Investment Analysis: Distribution by Year and Type of Funding, Since 2013
  • Table 14.43 Funding and Investment Analysis: Summary of Investments, Since 2013 (USD Million)
  • Table 14.44 Funding and Investment Analysis: Distribution by Geography
  • Table 14.45 Funding and Investment Analysis: Regional Distribution of Funding Instances
  • Table 14.46 Most Active Players: Distribution by Number of Funding Instances
  • Table 14.47 Most Active Players: Distribution by Amount Invested
  • Table 14.48 Funding and Investment Analysis: Distribution by Type of Investor
  • Table 14.49 Key Investors: Distribution by Number of Funding Instances
  • Table 14.50 Funding and Investment Analysis: Distribution by Purpose of Investment
  • Table 14.51 Funding and Investment Analysis: Distribution by Application Area
  • Table 14.52 Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices, Till 2035 (USD Million)
  • Table 14.53 Global At-Home Blood Collection and Micro Sampling Device Market, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.54 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Blood Sample State, Till 2035 (USD Million)
  • Table 14.55 At-Home Blood Collection and Micro Sampling Device Market for Dried Blood Samples, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.56 At-Home Blood Collection and Micro Sampling Device Market for Liquid Blood Samples, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.57 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Method of Sample Collection, Till 2035 (USD Million)
  • Table 14.58 At-Home Blood Collection and Micro Sampling Device Market for Fingerstick Method of Sample Collection, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.59 At-Home Blood Collection and Micro Sampling Device Market for Push-Button Method of Sample Collection, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.60 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Device Usage, Till 2035 (USD Million)
  • Table 14.61 At-Home Blood Collection and Micro Sampling Device Market for Single-use Devices, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.62 At-Home Blood Collection and Micro Sampling Device Market for Reusable Devices, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.63 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Areas of Application, Till 2035 (USD Million)
  • Table 14.64 At-Home Blood Collection and Micro Sampling Device Market for Diagnostics Purposes, Conservative, Base and Optimistic Scenarios, Till 2031 (USD Million)
  • Table 14.65 At-Home Blood Collection and Micro Sampling Device Market for Research Purposes, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.66 At-Home Blood Collection and Micro Sampling Device Market for Therapeutics Purposes, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.67 At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.68 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Region, Till 2035 (USD Million)
  • Table 14.69 At-Home Blood Collection and Micro Sampling Device Market in North America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.70 At-Home Blood Collection and Micro Sampling Device Market in Europe, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.71 At-Home Blood Collection and Micro Sampling Device Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.72 At-Home Blood Collection and Micro Sampling Device Market in Latin America, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
  • Table 14.73 At-Home Blood Collection and Micro Sampling Device Market in MENA, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: Current Market Landscape
  • Figure 2.2 Executive Summary: Product Competitiveness Analysis
  • Figure 2.3 Executive Summary: Patent Analysis
  • Figure 2.4 Executive Summary: Partnerships and Collaborations
  • Figure 2.5 Executive Summary: Funding and Investment Analysis
  • Figure 2.6 Executive Summary: Cost Saving Analysis
  • Figure 2.7 Executive Summary: Market Sizing and Opportunity Analysis
  • Figure 3.1 Process of Sampling Dried Blood
  • Figure 4.1 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Class
  • Figure 4.2 At-Home Blood Collection and Micro Sampling Devices: Distribution by Current Status of Development
  • Figure 4.3 At-Home Blood Collection and Micro Sampling Devices: Distribution by Regulatory Approvals / Certifications Received
  • Figure 4.4 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Technology
  • Figure 4.5 At-Home Blood Collection and Micro Sampling Devices: Distribution by Device Usage
  • Figure 4.6 At-Home Blood Collection and Micro Sampling Devices: Distribution by Type of Sample
  • Figure 4.7 At-Home Blood Collection and Micro Sampling Devices: Distribution by Blood Sample State
  • Figure 4.8 At-Home Blood Collection and Micro Sampling Devices: Distribution by Volume of Sample Collected
  • Figure 4.9 At-Home Blood Collection and Micro Sampling Devices: Distribution by Puncture Site
  • Figure 4.10 At-Home Blood Collection and Micro Sampling Devices: Distribution by Method of Sample Collection
  • Figure 4.11 At-Home Blood Collection and Micro Sampling Devices: Distribution by Storage Temperature
  • Figure 4.12 At-Home Blood Collection and Micro Sampling Devices: Distribution by Application Area
  • Figure 4.13 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment
  • Figure 4.14 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Company Size
  • Figure 4.15 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Continent-wise)
  • Figure 4.16 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Location of Headquarters (Country-wise)
  • Figure 4.17 At-Home Blood Collection and Micro Sampling Device Developers: Distribution by Year of Establishment, Company Size and Location of Headquarters
  • Figure 4.18 Most Active Players: Distribution by Number of Products
  • Figure 4.19 Most Active Players: Distribution by Current Status of Development
  • Figure 5.1 Product Competitiveness Analysis: North America Scenario
  • Figure 5.2 Product Competitiveness Analysis: Europe Scenario
  • Figure 5.3 Product Competitiveness Analysis: Asia-Pacific Scenario
  • Figure 7.1 Patent Analysis: Distribution by Type of Patent
  • Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, Since 2015
  • Figure 7.3 Patent Analysis: Distribution by Type of Patent and Publication Year
  • Figure 7.4 Patent Analysis: Distribution by Geography
  • Figure 7.5 Patent Analysis: North America Scenario
  • Figure 7.6 Patent Analysis: Asia-Pacific Scenario
  • Figure 7.7 Patent Analysis: Distribution by CPC Symbols
  • Figure 7.8 Patent Analysis: Distribution by Emerging Focus Area
  • Figure 7.9 Most Active Players: Distribution by Number of Patents
  • Figure 7.10 Patent Benchmarking Analysis: Your Bio Health and Becton Dickinson
  • Figure 7.11 Patent Benchmarking Analysis: Other Leading Players
  • Figure 7.12 Patent Portfolio: Distribution by Patent Age
  • Figure 7.13 Patent Valuation Analysis
  • Figure 7.14 Overall Intellectual Property Portfolio: Distribution by Type of Organization
  • Figure 8.1 Partnerships: Cumulative Year-wise Trend, Since 2016
  • Figure 8.2 Partnerships: Distribution by Type of Partnership
  • Figure 8.3 Partnerships: Distribution by Year and Type of Partnership
  • Figure 8.4 Partnerships: Distribution by Focus Area
  • Figure 8.5 Partnerships: Distribution by Year of Partnership and Focus Area
  • Figure 8.6 Heat Map: Distribution by Type of Partnership and Focus Area
  • Figure 8.7 Partnerships: Distribution by Therapeutic Area
  • Figure 8.8 Partnerships: Continent-wise Distribution
  • Figure 8.9 Partnerships: Intercontinental and Intracontinental Agreements
  • Figure 8.10 Partnerships: Country-wise Distribution
  • Figure 8.11 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Number of Instances, Since 2013
  • Figure 9.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Since 2013 (USD Million)
  • Figure 9.3 Funding and Investment Analysis: Distribution by Type of Funding, Since 2013
  • Figure 9.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding, Since 2013 (USD Million)
  • Figure 9.5 Funding and Investment Analysis: Distribution by Year and Type of Funding, Since 2013
  • Figure 9.6 Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested, Since 2013 (USD Million)
  • Figure 9.7 Funding and Investment Analysis: Summary of Investments, Since 2013 (USD Million)
  • Figure 9.8 Funding and Investment Analysis: Distribution by Geography
  • Figure 9.9 Funding and Investment Analysis: Regional Distribution of Funding Instances
  • Figure 9.10 Most Active Players: Distribution by Number of Funding Instances
  • Figure 9.11 Most Active Players: Distribution by Amount Invested
  • Figure 9.12 Funding and Investment Analysis: Distribution by Type of Investor
  • Figure 9.13 Key Investors: Distribution by Number of Funding Instances
  • Figure 9.14 Funding and Investment Analysis: Distribution by Purpose of Investment
  • Figure 9.15 Funding and Investment Analysis: Distribution by Application Area
  • Figure 10.1 Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices, Till 2035 (USD Million)
  • Figure 11.1 Global At-Home Blood Collection and Micro Sampling Device Market, Till 2035 (USD Million)
  • Figure 11.2 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Blood Sample State, Till 2035 (USD Million)
  • Figure 11.3 At-Home Blood Collection and Micro Sampling Device Market for Dried Blood Samples, Till 2035 (USD Million)
  • Figure 11.4 At-Home Blood Collection and Micro Sampling Device Market for Liquid Blood Samples, Till 2035 (USD Million)
  • Figure 11.5 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Method of Sample Collection, Till 2035 (USD Million)
  • Figure 11.6 At-Home Blood Collection and Micro Sampling Device Market for Fingerstick Method of Sample Collection, Till 2035 (USD Million)
  • Figure 11.7 At-Home Blood Collection and Micro Sampling Device Market for Push-Button Method of Sample Collection, Till 2035 (USD Million)
  • Figure 11.8 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Device Usage, Till 2035 (USD Million)
  • Figure 11.9 At-Home Blood Collection and Micro Sampling Device Market for Single-use Devices, Till 2035 (USD Million)
  • Figure 11.10 At-Home Blood Collection and Micro Sampling Device Market for Reusable Devices, Till 2035 (USD Million)
  • Figure 11.11 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Areas of Application, Till 2035 (USD Million)
  • Figure 11.12 At-Home Blood Collection and Micro Sampling Device Market for Diagnostic Purposes, Till 2035 (USD Million)
  • Figure 11.13 At-Home Blood Collection and Micro Sampling Device Market for Research Purposes, Till 2035 (USD Million)
  • Figure 11.14 At-Home Blood Collection and Micro Sampling Device Market for Therapeutic Purposes, Till 2035 (USD Million)
  • Figure 11.15 At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, Till 2035 (USD Million)
  • Figure 11.16 At-Home Blood Collection and Micro Sampling Device Market: Distribution by Region, Till 2035 (USD Million)
  • Figure 11.17 At-Home Blood Collection and Micro Sampling Device Market in North America, Till 2035 (USD Million)
  • Figure 11.18 At-Home Blood Collection and Micro Sampling Device Market in Europe, Till 2035 (USD Million)
  • Figure 11.19 At-Home Blood Collection and Micro Sampling Device Market in Asia-Pacific, Till 2035 (USD Million)
  • Figure 11.20 At-Home Blood Collection and Micro Sampling Device Market in Latin America, Till 2035 (USD Million)
  • Figure 11.21 At-Home Blood Collection and Micro Sampling Device Market in MENA, Till 2035 (USD Million)
  • Figure 12.1 Concluding Remarks: Current Market Landscape
  • Figure 12.2 Concluding Remarks: Product Competitiveness Analysis
  • Figure 12.3 Concluding Remarks: Patent Analysis
  • Figure 12.4 Concluding Remarks: Partnerships and Collaborations
  • Figure 12.5 Concluding Remarks: Funding and Investment Analysis
  • Figure 12.6 Concluding Remarks: Market Sizing and Opportunity Analysis